Glivec and Urinary tract infection - a phase IV clinical study of FDA data
Summary:
We study 17,769 people who have side effects when taking Glivec. Urinary tract infection is found, especially among people who are female, 60+ old, have been taking the drug for 1 - 2 years, also take Janumet and have Chronic myeloid leukaemia.
The phase IV clinical study analyzes which people take Glivec and have Urinary tract infection. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
17,769 people reported to have side effects when taking Glivec.
Among them, 103 people (0.58%) have Urinary tract infection.
What is Glivec?
Glivec has active ingredients of imatinib mesylate. Currently, eHealthMe is studying from 17,777 Glivec users.
What is Urinary tract infection?
Urinary tract infection is found to be associated with 4,200 drugs and 3,828 conditions by eHealthMe. Currently, we are studying 263,910 people who have Urinary tract infection.
Number of Glivec and Urinary tract infection reports submitted per year:
Time on Glivec when people have Urinary tract infection *:
Gender of people who have Urinary tract infection when taking Glivec*:
Age of people who have Urinary tract infection when taking Glivec *:
Common drugs people take besides Glivec *:
Common side effects people have besides Urinary tract infection *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Glivec and have Urinary tract infection?
Check whether Urinary tract infection is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- O'rafferty C, McElligott F, Storey L, O'marcaigh A, Smith O, "Pneumatosis intestinalis and imatinib mesylate", Annals of hematology, 2014 Oct .
Related studies
Glivec side effects by duration, gender and age:
- Glivec side effects (17,777 reports)
Urinary tract infection treatments and more:
- Urinary tract infection (263,910 reports)
Common drugs associated with Urinary tract infection:
- Prednisone: 13,893 reports
- Aspirin: 11,407 reports
- Methotrexate: 10,843 reports
- Humira: 10,333 reports
- Tysabri: 9,886 reports
- Omeprazole: 9,060 reports
- Enbrel: 8,738 reports
- Metformin: 8,436 reports
- Vitamin d: 6,742 reports
- Gabapentin: 6,698 reports
All the drugs that are associated with Urinary tract infection:
- Urinary tract infection (4,200 drugs)
Common conditions associated with Urinary tract infection:
- Multiple sclerosis: 26,759 reports
- Rheumatoid arthritis: 23,040 reports
- High blood pressure: 10,386 reports
- Pain: 6,998 reports
- Osteoporosis: 6,846 reports
- Multiple myeloma: 6,760 reports
All the conditions that are associated with Urinary tract infection:
- Urinary tract infection (3,828 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on imatinib mesylate (the active ingredients of Glivec) and Glivec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Methylprednisolone and Stupor - a second ago
- Revia and Prednisone drug interaction - 2 seconds ago
- Lidocaine and Joint Effusion - 4 seconds ago
- Albuterol and Infected Cyst - 4 seconds ago
- Meprobamate and Breathing Difficulty - 6 seconds ago
- Voltaren and Pain Of Skin - 7 seconds ago
- Miralax and Hyperphosphataemia - 7 seconds ago
- Avonex and Concussion - 10 seconds ago
- Canasa and Oedema Peripheral - 14 seconds ago
- Lorazepam and Evening Primrose Oil drug interaction - 21 seconds ago